An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones
Further demonstrates Honeywell's commitment to greenhouse gas reduction and support of customers' sustainability goals through innovative new products
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Ind-Ra maintains a neutral outlook for healthcare in FY23
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
Subscribe To Our Newsletter & Stay Updated
